MRCT Center 2025 Annual Symposium - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
Meeting
October 22, 2025 @ 8:00 am – 6:00 pm
JOIN US! MRCT Center 2025 Annual Symposium
Join us for a full day of discussions and presentations on ethical, actionable, and practical solutions to today’s global clinical research challenges. Engage with regulators, industry leaders, patient advocates, and research experts to gain privileged insights, shape the conversation, and forge connections that drive real-world impact. The symposium is free and open to all registrants.
We are pleased to announce our keynote speaker: John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), a biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. John’s decades of biotech experience and deep passion for the field have made him a strong supporter of policies that empower innovation, enable entrepreneurship, and put people and patients first.
Other highlights of the agenda include the following:
- Rethinking Informed Consent with Artificial Intelligence: Opportunities and Challenges
- Cell and Gene Therapies Long-Term Follow-Up: Key Deliverables and the Path Forward
- Reinventing Informed Consent: Emerging from the Chrysalis
- Clinical Trial Reform: The Need for Change and Progress
On Thursday morning, October 23, the MRCT Center will hold a joint meeting in concert with the Vivli annual meeting. Researchers, data contributors, and funders will discuss the journey from data contribution to impact in clinical trial methodology, oncology, and Type 1 diabetes. Sessions will focus on learnings from data challenges, the latest in sharing imaging data, as well as how to apply the latest DOJ ruling on sharing data with countries of concern. This event is also complimentary and open to all Symposium registrants.
Register today to secure your spot and help drive responsible innovation in clinical trials.